The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q)

British Journal of Haematology

Volumn 166, Issue 4, 2014, Pages 550-556

  Mcnerney, Megan E ^a,b   Brown, Christopher D ^c   Peterson, April L ^a   Banerjee, Mekhala ^b   Larson, Richard A ^b   Anastasi, John ^b   Le Beau, Michelle M ^a,b   White, Kevin P ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CUX1; Monosomy 7; Myeloid leukaemia

Indexed keywords

TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME DELETION; COPY NUMBER VARIATION; CYTOGENETICS; DNA METHYLATION; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; KARYOTYPE; MONOSOMY 7; MORPHOLOGY; OVERALL SURVIVAL; PRIORITY JOURNAL; RNA SEQUENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

CUX1; MONOSOMY 7; MYELOID LEUKAEMIA;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; NUCLEAR PROTEINS; REPRESSOR PROTEINS; RISK FACTORS;

EID: 84905030391     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12964     Document Type: Article

References (12)

1. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A.P., Sander, C. & Schultz, N. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2, 401-404.
2. Cooper, G.M., Stone, E.A., Asimenos, G., Green, E.D., Batzoglou, S. & Sidow, A. (2005) Distribution and intensity of constraint in mammalian genomic sequence. Genome Research, 15, 901-913.
3. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. & Stratton, M.R. (2004) A census of human cancer genes. Nature Reviews Cancer, 4, 177-183.
4. Grimwade, D., Hills, R.K., Moorman, A.V., Walker, H., Chatters, S., Goldstone, A.H., Wheatley, K., Harrison, C.J. & Burnett, A.K. (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116, 354-365.
5. Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.M., Head, D.R., Appelbaum, F.R. & Willman, C.L. (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood, 89, 3323-3329.
6. Link, D.C., Schuettpelz, L.G., Shen, D., Wang, J., Walter, M.J., Kulkarni, S., Payton, J.E., Ivanovich, J., Goodfellow, P.J., Le Beau, M., Koboldt, D.C., Dooling, D.J., Fulton, R.S., Bender, R.H., Fulton, L.L., Delehaunty, K.D., Fronick, C.C., Appelbaum, E.L., Schmidt, H., Abbott, R., O'Laughlin, M., Chen, K., McLellan, M.D., Varghese, N., Nagarajan, R., Heath, S., Graubert, T.A., Ding, L., Ley, T.J., Zambetti, G.P., Wilson, R.K. & Mardis, E.R. (2011) Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. Journal of the American Medical Association, 305, 1568-1576.
7. McNerney, M.E., Brown, C.D., Wang, X., Bartom, E.T., Karmakar, S., Bandlamudi, C., Yu, S., Ko, J., Sandall, B.P., Stricker, T., Anastasi, J., Grossman, R.L., Cunningham, J.M., Le Beau, M.M. & White, K.P. (2013) CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood, 121, 975-983.
8. Schoch, C., Kern, W., Schnittger, S., Hiddemann, W. & Haferlach, T. (2004) Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia, 18, 120-125.
9. Side, L.E., Curtiss, N.P., Teel, K., Kratz, C., Wang, P.W., Larson, R.A., Le Beau, M.M. & Shannon, K.M. (2004) RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7. Genes Chromosomes Cancer, 39, 217-223.
10. Smith, S.M., Le Beau, M.M., Huo, D., Karrison, T., Sobecks, R.M., Anastasi, J., Vardiman, J.W., Rowley, J.D. & Larson, R.A. (2003) Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood, 102, 43-52.
11. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoieitc and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, France.
12. TCGA (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The Cancer Genome Atlas Research Network. New England Journal of Medicine, 368, 2059-2074.